1
TÍTULO: HELIOS-A: 9-month results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy  Full Text
AUTORES: Adams, D; Tournev, I; Taylor, M; Coelho, T; Plante Bordeneuve, V; Berk, J; Gonzalez Duarte, A; Gillmore, J; Low, SC; Sekijima, Y; Obici, L; Blakesley, R; Arum, S; Shilling, R; Vest, J; Polydefkis, M;
PUBLICAÇÃO: 2021, FONTE: JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, VOLUME: 26, NÚMERO: 3
INDEXADO EM: WOS